Capping agent-dependent toxicity and antimicrobial activity of silver nanoparticles: An in vitro study. concerns about potential application in dental practice

International Journal of Medical Sciences

Volumn 13, Issue 10, 2016, Pages 772-782

  Niska, Karolina ^a   Knap, Narcyz ^a   Kędzia, Anna ^a   Jaskiewicz, Maciej ^a   Kamysz, Wojciech ^a   Inkielewicz Stepniak, Iwona ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Antibacterial activity; Antibiofilm activity; Capping agent; Cytotoxicity; Human gingival fibroblasts; Silver nanoparticles

Indexed keywords

SILVER NANOPARTICLE; ANTIINFECTIVE AGENT; DENTAL MATERIAL; MACROGOL DERIVATIVE; METAL NANOPARTICLE; SILVER; TANNIN DERIVATIVE; THIOCTIC ACID;

AGAR DILUTION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOFILM; BROTH DILUTION; CONTROLLED STUDY; CYTOTOXICITY; HGF-1 CELL LINE; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; MOUTH INFECTION; MTT ASSAY; NONHUMAN; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS MUTANS; ANAEROBIC BACTERIUM; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GINGIVA; MICROBIAL SENSITIVITY TEST; PARTICLE SIZE;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BIOFILMS; CELLS, CULTURED; DENTAL MATERIALS; FIBROBLASTS; GINGIVA; HUMANS; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SILVER; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS MUTANS; TANNINS; THIOCTIC ACID;

EID: 85016438743     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.16011     Document Type: Article

References (72)

1. Alexander JW. History of the medical use of silver. Surg Infect. 2009; 10: 289-292.
2. Ip M, Lui SL, Poon VK, et al. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol, 2006; 55: 59-63.
3. Lu Z, Rong K, Li J, et al. Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria. J Mater Sci Mater Med. 2013; 24: 1465-1471.
4. Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem. 1994; 31: 351-370.
5. García-Contreras R, Argueta-Figueroa L, Mejía-Rubalcava C, et al. Perspectives for the use of silver nanoparticles in dental practice. Int Dent J. 2011; 61: 297-301.
6. Service RF. Nanotoxicology. Nanotechnology grows up. Science. 2004; 304: 1732-1734.
7. Saion E, Gharibshaki E, Naghavi K. Size-Controlled and Optical Properties of Monodispersed Silver Nanoparticles Synthesized by the Radiolytic Reduction Method. Int J Mol Sci. 2013; 14: 7880-7896.
8. Brandt O, Mildner M, Egger AE, et al. Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine. Nanomedicine. 2012; 8: 478-488.
9. Marambio-Jones C, Hoek EMV. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res. 2010; 12: 1531-1551.
10. Mohanty S, Mishra S, Jena P, et al. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine. 2012; 8: 916-924.
11. Gajbhiye M, Kesharwani JA, Ingle A, et al. Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomedicine. 2009; 5: 382-386.
12. Fayaz AM, Balaji K, Girilal M, et al. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine. 2010; 6: 103-109.
13. Nanda A, Saravanan M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine. 2009; 5: 452-456.
14. Strydom SJ, Rose WE, Otto DP, et al. Poly(amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity. Nanomedicine. 2013; 9: 85-93.
15. Slane J, Vivanco J, Rose W, et al. Mechanical, material, and antimicrobial properties of acrylic bone cement impregnated with silver nanoparticles. Mater Sci Eng C Mater Biol Appl. 2015; 48: 188-196.
16. Shawky HA, Soha MB, Gihan AELB, et al. Evaluation of Clinical and Antimicrobial Efficacy of Silver Nanoparticles and Tetracycline Films in the Treatment of Periodontal Pockets. IOSR J Dental Med Sci. 2015; 14: 113-123.
17. Saga T, Yamaguchi K. History of Antimicrobial Agents and Resistant Bacteria. Japan Med Assoc J. 2009; 52: 103-108.
18. Rautema R, Lauhio A, Cullinan MP, et al. Oral infections and systemic disease-an emerging problem in medicine. Clin Microbiol Infect. 2007; 13: 1041-1047.
19. Eaton KA. Global oral public health-the current situation and recent developments. J Public Health Policy. 2012; 33: 382-386.
20. Nikolaev YuA, Plakunov VK. Biofilm-“City of Microbes” or an Analogue of Multicellular Organisms? Microbiology. 2007; 76: 125-138.
21. Potera C. Antibiotic resistance: Biofilm dispersing agent rejuvenates older antibiotics. Environ Health Perspect. 2010; 118: A288-A291.
22. Li X, Kolltveit KM, Tronstad L, et al. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000; 13: 547-558.
23. Corrêa JM, Mori M, Sanches HL, et al. Silver nanoparticles in dental biomaterials. Int J Biomater. 2015; 2015: 1-9.
24. Singh S, Nalwa HS. Nanotechnology and health safety-toxicity and risk assessments of nanostructured materials on human health. J Nanosci Nanotechnol. 2007; 7: 3048-3070.
25. Inkielewicz-Stepniak I, Santos-Martinez MJ, Medina C, et al. Pharmacological and toxicological effects of co-exposure of human gingival fibroblasts to silver nanoparticles and sodium fluoride. Int J Nanomedicine, 2014; 9: 1677-1687.
26. Zhang T, Wang L, Chen Q, Chen Ch. Cytotoxic potential of silver nanoparticles. Yonsei Med J. 2014; 55: 283-291.
27. Taleghani F, Yaraii R, Sadeghi R, et al. Cytotoxicity of silver nanoparticles on human gingival epithelial cells: An in vitro study. J Dent Sci. 2014; 32: 30-36.
28. Grade S, Eberhard J, Jakobi J, et al. Alloying colloidal silver nanoparticles with gold disproportionally controls antibacterial and toxic effects. Goll Bull. 2014; 47: 83-93.
29. Jiang J, Oberdörster G, Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res. 2009; 11: 77-89.
30. [Internet] Nanocomposix. http://nanocomposix.eu/collections/silverspheres/products/10-nm-silver-nanospheres#example-specification-sheet.
31. Holdeman LV, Moore WEC. Anaerobe laboratory manual. Blacksburg, Virginia: VPI. Anaerobe Laboratory; 1977.
32. Holt JG. Bergey's manual of determinative bacteriology. Baltimore: Williams and Wilkins; 1994.
33. Forbes BA, Sahn DF, Weissfeld AS. Bailey and Scott's diagnostic microbiology, 12th ed. St. Louis, MO: Mosby Elsevier; 2007: 778-781.
34. Hecht DW, Citron DM, Cox M, et al. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standards, 8rd ed. USA: Clinical and Laboratory Standards Institute: Wayne PA 19087; 2012.
35. Murdock RC, Braydich-Stolle L, Schrand AM, et al. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci. 2007; 101: 239-253.
36. Ates M, Daniels J, Arslan Z, et al. Comparative evaluation of impact of Zn and ZnO nanoparticles on brine shrimp (Artemia salina)larvae: effects of particle size and solubility on toxicity. Environ Sci Process Impacts. 2013; 15: 225-233.
37. Jiang J, Oberdörster G, Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res. 2009; 11: 77-89.
38. Chiang SL, Jiang SS, Wang YJ, et al. Characterization of arecoline-induced effects on cytotoxicity in normal human gingival fibroblasts by global gene expression profiling. Toxicol Sci. 2007; 100: 66-74.
39. Urcan E, Haertel U, Styllou M, et al. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dent Mater. 2010; 26: 51-58.
40. Jaiswal S, Duffy B, Jaiswal AK, et al. Enhancement of the antibacterial properties of silver nanoparticles using beta-cyclodextrin as a capping agent. Int J Antimic Agents. 2010; 36: 280-283.
41. Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2011; 40: 1647-1671.
42. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature. 2004; 428: 487-492.
43. Liu X, Huang H, Liu G, et al. Multidentate zwitterionic chitosan oligosaccharide modified gold nanoparticles: stability, biocompatibility and cell interactions. Nanoscale. 2013; 5: 3982-3991.
44. Spacciapoli P, Buxton D, Rothstein D, Friden P. Antimicrobial activity of silver nitrate against periodontal pathogens. J Periodontal Res. 2001; 36: 108-113.
45. Duffin S. Back to the future: the medical management of caries introduction. J Calif Dent Assoc. 2012; 40: 852-858.
46. Chu CH, Gao SS, Li SK, Wong MC, Lo EC. The effectiveness of the biannual application of silver nitrate solution followed by sodium fluoride varnish in arresting early childhood caries in preschool children: study protocol for a randomised controlled trial. Trials. 2015; 16: 426.
47. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008; 3: 133-149.
48. Ahmad T. Reviewing the tannic acid mediated synthesis of metal nanoparticles. J Nanotechnol. 2014; 2014:1-11.
49. Anand N, Ramudu P, Reddy KHP, et al. Gold nanoparticles immobilized on lipoic acid functionalized SBA-15: Synthesis, characterization and catalytic applications. Appl Catal A. 2013; 454: 119-126.
50. Abiodun-Solanke IMF, Ajayi DM, Arigbede AQ. Nanotechnology and its application in dentistry. Ann Med Health Sci Res. 2014; 4: S171-S177.
51. Besinis A, De Peralta T, Tredwin CJ, et al. Review of nanomaterials in dentistry: Interactions with the oral microenvironment, clinical applications, hazards and benefits. ACS Nano. 2015; 9: 2255-2289.
52. Gliga AR, Skoglund S, Wallinder IO, et al. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol 2014; 11: 11.
53. Yu M, Huang S, Yu KJ, et al. Dextran and Polymer Polyethylene Glycol (PEG) Coating Reduce Both 5 and 30 nm Iron Oxide Nanoparticle Cytotoxicity in 2D and 3D Cell Culture. Int J Mol Sci. 2012; 13: 5554-5570.
54. DeBrosse MC, Comfort KK, Untener EA, et al. High aspect ratio gold nanorods displayed augmented cellular internalization and surface chemistry mediated cytotoxicity. Mater Sci Eng C Mater Biol Appl. 2013; 33: 4094-4100.
55. Lee K, Browning LM, Nallathamby PD, et al. Study of charge-dependent transport and toxicity of peptide-functionalized silver nanoparticles using zebrafish embryos and single nanoparticle plasmonic spectroscopy. Chem Res Toxicol. 2013; 26: 904-917.
56. Pettegrew C, Dong Z, Muhi MZ, et al. Silver Nanoparticle Synthesis Using Monosaccharides and Their Growth Inhibitory Activity against Gram-Negative and Positive Bacteria. ISRN Nanotechnology. 2014; 1-8.
57. El Badawy AM, Silva RG, Morris B, et al. Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol. 2011; 45: 283-287.
58. Abdel-Mohsen AM, Hrdina R, Burgert L, et al. Antibacterial activity and cell viability of hyaluronan fiber with silver nanoparticles. Carbohydr Polym. 2013; 92: 1177-1187.
59. Amato E, Diaz-Fernandez YA, Taglietti A, et al. Synthesis, characterization and antibacterial activity against Gram-positive and Gram-negative bacteria of biomimetically coated silver nanoparticles. Langmuir. 2011; 27: 9165-9173.
60. Goswami SR, Sahareen T, Singh M, et al. Role of biogenic silver nanoparticles in disruption of cell–cell adhesion in Staphylococcus aureus and Escherichia coli biofilm. J Ind Eng Chem. 2015; 26: 73-80.
61. Pérez-Díaz MA, Boegli L, James G, et al. Silver nanoparticles with antimicrobial activities against Streptococcus mutans and their cytotoxic effect. Mater Sci Eng C Mater Biol Appl. 2015; 55: 360-366.
62. Franci G, Falanga A, Galdiero S, et al. Silver nanoparticles as potential antibacterial agents. Molecules. 2015; 20: 8856-8874.
63. Ogawa A, Furukawa S, Fujita S, et al. Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA. Appl Environ Microbiol. 2011; 77: 1572-1580.
64. McCormack MG, Smith AJ, Akram AN, et al. Staphylococcus aureus and the oral cavity: an overlooked source of carriage and infection? Am J Infect Control. 2015; 43: 35-37.
65. Archer NK, Mazaitis MJ, Costerton JW, et al. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence. 2011; 2: 445-459.
66. Loberto JCS, Martins CAP, Santos SSF, et al. Staphylococcus spp. in the oral cavity and periodontal pockets of chronic periodontitis patients. Braz J Microbiol. 2004; 35: 64-68.
67. Cuesta AI, Jewtuchowicz V, Brusca MI, et al. Prevalence of Staphylococcus spp and Candida spp in the oral cavity and periodontal pockets of periodontal disease patients. Acta Odontol Latinoam. 2010; 23:20-26.
68. Padovani GC, Feitosa VP, Sauro S, et al. Advances in Dental Materials through Nanotechnology: Facts, Perspectives and Toxicological Aspects. Trends Biotechnol. 2015; 33: 621-636.
69. Hernández-Sierra JF, Ruiz F, Pena DC, et al. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold. Nanomedicine. 2008; 4: 237-240.
70. Espinosa-Cristóbal LF, Martínez-Castañón GA, Téllez-Déctor EJ, et al. Adherence inhibition of Streptococcus mutans on dental enamel surface using silver nanoparticles. Mater Sci Eng C Mater Biol Appl. 2013; 33: 2197-2202.
71. Kalishwaralal K, BarathManiKanth S, Pandian SR, et al. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces. 2010; 79: 340-344.
72. Gurunathan S, Han JW, Kwon DN, et al. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett. 2014; 9: 373.